{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:17:22Z","timestamp":1794003442019,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Research Fund of Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital","award":["2022QN55"],"award-info":[{"award-number":["2022QN55"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32141002 and 82172311"],"award-info":[{"award-number":["32141002 and 82172311"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10096-025-05180-y","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T05:04:26Z","timestamp":1749877466000},"page":"2197-2206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Emergence of ceftazidime-avibactam resistance in clinical Klebsiella pneumoniae during therapy"],"prefix":"10.1007","volume":"44","author":[{"given":"Siquan","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiren","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fupin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"issue":"6","key":"5180_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1473-3099(19)30755-8","volume":"20","author":"D van Duin","year":"2020","unstructured":"van Duin D, Arias CA, Komarow L et al (2020) Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. Lancet Infect Dis 20(6):731\u2013741","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"5180_CR2","doi-asserted-by":"publisher","first-page":"e0000823","DOI":"10.1128\/cmr.00008-23","volume":"36","author":"L Ding","year":"2023","unstructured":"Ding L, Shen S, Chen J et al (2023) Klebsiella pneumoniae carbapenemase variants: the new threat to global public health. Clin Microbiol Rev 36(4):e0000823","journal-title":"Clin Microbiol Rev"},{"key":"5180_CR3","doi-asserted-by":"crossref","unstructured":"Tumbarello M, Raffaelli F, Giannella M et al (2021) Ceftazidime-avibactam use for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infections: a retrospective observational multicenter study. Clin Infect Dis\u00a0\u00a073(9):1664\u20131676","DOI":"10.1093\/cid\/ciab176"},{"key":"5180_CR4","doi-asserted-by":"crossref","unstructured":"Tumbarello M, Trecarichi EM, Corona A et al (2019) Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin Infect Dis\u00a068(3):355\u2013364","DOI":"10.1093\/cid\/ciy492"},{"issue":"3","key":"5180_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/cid\/ciy576","volume":"68","author":"JM Pogue","year":"2019","unstructured":"Pogue JM, Bonomo RA, Kaye KS (2019) Ceftazidime\/Avibactam, Meropenem\/Vaborbactam, or Both? Clinical and Formulary Considerations. Clin Infect Dis 68(3):519\u2013524","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5180_CR6","doi-asserted-by":"publisher","first-page":"e02097","DOI":"10.1128\/AAC.02097-16","volume":"61","author":"RK Shields","year":"2017","unstructured":"Shields RK, Chen L, Cheng S et al (2017) Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla(KPC-3) Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections. Antimicrob Agents Chemother 61(3):e02097-e2116","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5180_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s12223-021-00918-5","volume":"66","author":"NK Moreira","year":"2021","unstructured":"Moreira NK, Caier\u00e3o J (2021) Ceftazidime-avibactam: are we safe from class A carbapenemase producers\u2019 infections? Folia Microbiol (Praha) 66(6):879\u2013896","journal-title":"Folia Microbiol (Praha)"},{"issue":"9","key":"5180_CR8","doi-asserted-by":"publisher","first-page":"e0089021","DOI":"10.1128\/AAC.00890-21","volume":"65","author":"J Findlay","year":"2021","unstructured":"Findlay J, Poirel L, Juhas M, Nordmann P (2021) KPC-Mediated Resistance to Ceftazidime-Avibactam and Collateral Effects in Klebsiella pneumoniae. Antimicrob Agents Chemother 65(9):e0089021","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"5180_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3390\/antibiotics11050604","volume":"11","author":"L Ding","year":"2022","unstructured":"Ding L, Shen S, Han R, Yin D, Guo Y, Hu F (2022) Ceftazidime-Avibactam in Combination with Imipenem as Salvage Therapy for ST11 KPC-33-Producing Klebsiella pneumoniae. Antibiotics (Basel) 11(5):604","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"5180_CR10","doi-asserted-by":"publisher","first-page":"2356146","DOI":"10.1080\/22221751.2024.2356146","volume":"13","author":"S Shen","year":"2024","unstructured":"Shen S, Tang C, Yang W et al (2024) In vitro mimicry of in vivo KPC mutations by ceftazidime-avibactam: phenotypes, mechanisms, genetic structure and kinetics of enzymatic hydrolysis. Emerg Microbes Infect 13(1):2356146","journal-title":"Emerg Microbes Infect"},{"key":"5180_CR11","doi-asserted-by":"crossref","unstructured":"Humphries R, Bobenchik AM, Hindler JA, Schuetz AN (2021) Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100, 31st edition. J Clin Microbiol\u00a0\u00a059(12):e0021321","DOI":"10.1128\/JCM.00213-21"},{"key":"5180_CR12","doi-asserted-by":"crossref","unstructured":"Wagoner KG, Lazard AJ, Romero-Sandoval EA, Reboussin BA (2021) Health claims about cannabidiol products: a retrospective analysis of U.S. food and drug administration warning letters from 2015 to 2019. Cannabis Cannabinoid Res\u00a06(6):559\u2013563","DOI":"10.1089\/can.2020.0166"},{"issue":"3","key":"5180_CR13","doi-asserted-by":"publisher","first-page":"e0027621","DOI":"10.1128\/jcm.00276-21","volume":"60","author":"CG Giske","year":"2022","unstructured":"Giske CG, Turnidge J, Cant\u00f3n R, Kahlmeter G (2022) Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST). J Clin Microbiol 60(3):e0027621","journal-title":"J Clin Microbiol"},{"issue":"6","key":"5180_CR14","doi-asserted-by":"publisher","first-page":"106211","DOI":"10.1016\/j.ijantimicag.2020.106211","volume":"56","author":"JG Routsias","year":"2020","unstructured":"Routsias JG, Tsakogiannis D, Katsiki M et al (2020) Development of a new spectrophotometric assay for rapid detection and differentiation of KPC, MBL and OXA-48 carbapenemase-producing Klebsiella pneumoniae clinical isolates. Int J Antimicrob Agents 56(6):106211","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"5180_CR15","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1128\/JCM.06094-11","volume":"50","author":"MV Larsen","year":"2012","unstructured":"Larsen MV, Cosentino S, Rasmussen S et al (2012) Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol 50(4):1355\u20131361","journal-title":"J Clin Microbiol"},{"issue":"7","key":"5180_CR16","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1128\/AAC.02412-14","volume":"58","author":"A Carattoli","year":"2014","unstructured":"Carattoli A, Zankari E, Garc\u00eda-Fern\u00e1ndez A et al (2014) In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother 58(7):3895\u20133903","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"5180_CR17","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1093\/jac\/dks261","volume":"67","author":"E Zankari","year":"2012","unstructured":"Zankari E, Hasman H, Cosentino S et al (2012) Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67(11):2640\u20132644","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"5180_CR18","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s10096-024-04910-y","volume":"43","author":"Y Gong","year":"2024","unstructured":"Gong Y, Feng Y, Zong Z, Lv X (2024) Characterization of a KPC-84 harboring Klebsiella pneumoniae ST11 clinical isolate with ceftazidime-avibactam resistance. Eur J Clin Microbiol Infect Dis 43(10):2029\u20132035","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"5180_CR19","doi-asserted-by":"publisher","first-page":"e02101","DOI":"10.1128\/AAC.02101-17","volume":"62","author":"MJ Giddins","year":"2018","unstructured":"Giddins MJ, Macesic N, Annavajhala MK et al (2018) Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in bla(KPC-2)-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates. Antimicrob Agents Chemother 62(3):e02101-e2117","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 4","key":"5180_CR20","doi-asserted-by":"publisher","first-page":"S436","DOI":"10.1093\/cid\/ciaa1521","volume":"71","author":"Q Shi","year":"2020","unstructured":"Shi Q, Yin D, Han R et al (2020) Emergence and Recovery of Ceftazidime-avibactam Resistance in blaKPC-33-Harboring Klebsiella pneumoniae Sequence Type 11 Isolates in China. Clin Infect Dis 71(Suppl 4):S436-s439","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5180_CR21","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s15010-022-01876-x","volume":"50","author":"S Zhen","year":"2022","unstructured":"Zhen S, Wang H, Feng S (2022) Update of clinical application in ceftazidime-avibactam for multidrug-resistant Gram-negative bacteria infections. Infection 50(6):1409\u20131423","journal-title":"Infection"},{"key":"5180_CR22","doi-asserted-by":"crossref","unstructured":"Doi Y (2019) Treatment Options for carbapenem-resistant gram-negative bacterial infections. Clin Infect Dis\u00a0\u00a069(Suppl 7):S565-s575","DOI":"10.1093\/cid\/ciz830"},{"issue":"5","key":"5180_CR23","doi-asserted-by":"publisher","first-page":"e02497","DOI":"10.1128\/AAC.02497-17","volume":"62","author":"RK Shields","year":"2018","unstructured":"Shields RK, Nguyen MH, Chen L, Press EG, Kreiswirth BN, Clancy CJ (2018) Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections. Antimicrob Agents Chemother 62(5):e02497-e2517","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"5180_CR24","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/jac\/dkv094","volume":"70","author":"ML Winkler","year":"2015","unstructured":"Winkler ML, Papp-Wallace KM, Bonomo RA (2015) Activity of ceftazidime\/avibactam against isogenic strains of Escherichia coli containing KPC and SHV \u03b2-lactamases with single amino acid substitutions in the \u03a9-loop. J Antimicrob Chemother 70(8):2279\u20132286","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"5180_CR25","doi-asserted-by":"publisher","first-page":"e0044722","DOI":"10.1128\/aac.00447-22","volume":"66","author":"CA Hobson","year":"2022","unstructured":"Hobson CA, Pierrat G, Tenaillon O et al (2022) Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview. Antimicrob Agents Chemother 66(9):e0044722","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"5180_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.tim.2014.09.003","volume":"22","author":"L Chen","year":"2014","unstructured":"Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN (2014) Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol 22(12):686\u2013696","journal-title":"Trends Microbiol"},{"issue":"1","key":"5180_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/22221751.2021.2013105","volume":"11","author":"Y Tang","year":"2022","unstructured":"Tang Y, Li G, Shen P, Zhang Y, Jiang X (2022) Replicative transposition contributes to the evolution and dissemination of KPC-2-producing plasmid in Enterobacterales. Emerg Microbes Infect 11(1):113\u2013122","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"5180_CR28","doi-asserted-by":"publisher","first-page":"107265","DOI":"10.1016\/j.ijantimicag.2024.107265","volume":"64","author":"C Tang","year":"2024","unstructured":"Tang C, Shen S, Yang W et al (2024) Complex evolutionary trajectories in vivo of two novel KPC variants conferring ceftazidime-avibactam resistance. Int J Antimicrob Agents 64(3):107265","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"5180_CR29","doi-asserted-by":"publisher","first-page":"e0095421","DOI":"10.1128\/Spectrum.00954-21","volume":"9","author":"L Ding","year":"2021","unstructured":"Ding L, Shi Q, Han R et al (2021) Comparison of Four Carbapenemase Detection Methods for bla(KPC-2) Variants. Microbiol Spectr 9(3):e0095421","journal-title":"Microbiol Spectr"},{"issue":"7","key":"5180_CR30","doi-asserted-by":"publisher","first-page":"e0015424","DOI":"10.1128\/jcm.00154-24","volume":"62","author":"J Zhang","year":"2024","unstructured":"Zhang J, Xu J, Shen S et al (2024) Comparison of three colloidal gold immunoassays and GeneXpert Carba-R for the detection of Klebsiella pneumoniae bla(KPC-2) variants. J Clin Microbiol 62(7):e0015424","journal-title":"J Clin Microbiol"},{"issue":"1","key":"5180_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/pathogens10010067","volume":"10","author":"M Hern\u00e1ndez-Garc\u00eda","year":"2021","unstructured":"Hern\u00e1ndez-Garc\u00eda M, S\u00e1nchez-L\u00f3pez J, Mart\u00ednez-Garc\u00eda L et al (2021) Emergence of the New KPC-49 Variant Conferring an ESBL Phenotype with Resistance to Ceftazidime-Avibactam in the ST131-H30R1 Escherichia coli High-Risk Clone. Pathogens 10(1):67","journal-title":"Pathogens"},{"issue":"3","key":"5180_CR32","doi-asserted-by":"publisher","first-page":"e0224521","DOI":"10.1128\/jcm.02245-21","volume":"60","author":"M Hern\u00e1ndez-Garc\u00eda","year":"2022","unstructured":"Hern\u00e1ndez-Garc\u00eda M, Castillo-Polo JA, Cordero DG et al (2022) Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection. J Clin Microbiol 60(3):e0224521","journal-title":"J Clin Microbiol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05180-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05180-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05180-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:13:06Z","timestamp":1758719586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05180-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["5180"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05180-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}